179
Views
0
CrossRef citations to date
0
Altmetric
Research Articles

Role of cholinergic agents in proliferation and caspase activity of hemin-induced erythroid differentiated K562 cells

ORCID Icon & ORCID Icon
Pages 42-48 | Received 22 Nov 2019, Accepted 29 Dec 2019, Published online: 07 Jan 2020

References

  • Wessler I, Kirkpatrick CJ, Racke K. The cholinergic ‘pitfall’: acetylcholine, a universal cell molecule in biological systems, including humans. Clin Exp Pharmacol Physiol. 1999;26(3):198–205.
  • Eglen RM. Muscarinic receptor subtypes in neuronal and nonneuronal cholinergic function. Autonom Auta Pharm. 2006;26(3):219–233.
  • Paleari L, Grozio A, Cesario A, et al. The cholinergic system and cancer. Semin Cancer Biol. 2008;18(3):211–217.
  • Cabadak H, Küçükibrahimoğlu E, Aydin B, et al. Muscarinic receptor-mediated nitric oxide release in a K562 erythroleukaemia cell line. Auton Autacoid Pharmacol. 2009;29(3):109–115.
  • Aydın B, Kan B, Cabadak H. The role of intracellular pathways in the proliferation of human K562 cells that is mediated by muscarinic receptors. Leukemia Res. 2013;37(9):1144–1149.
  • Cabadak H, Aydin B, Kan B. Regulation of M2, M3, and M4 muscarinic receptor expression in K562 chronic myelogenous leukemic cells by carbachol. J Recept Signal Transd Res. 2011;31(1):26–32.
  • Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407(6805):770–776.
  • Parrish AB, Freel CD, Kornbluth S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol. 2013;5:pii: a008672.
  • Lanzafame A, Christopoulos A, Mitchelson F. Cellular signaling mechanisms for muscarinic acetylcholine receptors. Recept Channels. 2003;9(4):241–260.
  • Nicke B, Detjen K, Logsdon C. Muscarinic cholinergic receptors activate both inhibitory and stimulatory growth mechanisms in NIH3T3 cells. J Biol Chem. 1999;274(31):21701–21706.
  • Sales ME. Muscarinic receptors as targets for metronomic therapy in breast cancer. Curr Pharm Design. 2016;14:2170–2177.
  • Ukegawa JI, Takeuchi Y, Kusayanagi SK, et al. Growth-promoting effect of muscarinic acetylcholine receptors in colon cancer cells. J Cancer Res Clin Oncol. 2003;129(5):272–278.
  • Lozzio CB, Lozzio BB. Human chronic myelogenous leukemia cell line with positive Philadelphia chromosome. Blood. 1975;45(3):321–334.
  • Gahmberg CG, Ekblom M, Andersson LC. Differentiation of human erythroid cells is associated with increased O-glycosylation otthe major sialoglycoprotein, glycophorin A (erythrocyte differentiation/mabria/erythroleukemia). Proc Natl Acad Sci USA. 1984;81(21):6752–6756.
  • Wessler I, Kirkpatrick CJ, Racké K. Non-neuronal acetylcholine, a locally acting molecule, widely distributed in biological systems: expression and function in humans. Pharmacol Ther. 1998;77(1):59–79.
  • Wessler I, Kirkpatrick CJ. Acetylcholine beyond neurons: the nonneuronal cholinergic system in humans. Br J Pharmacol. 2009;154(8):1558–1571.
  • Lowry OH, Rosebrough NJ, Farr AL, et al. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951;193(1):265–275.
  • Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281(5381):1309–1312.
  • Takahashi T, Ohnishi H, Sugiura Y, et al. Non-neuronal acetylcholine as an endogenous regulator of proliferation and differentiation of Lgr5-positive stem cells in mice. FEBS J. 2014;281(20):4672–4690.
  • Tolaymat M, Larabee SM, Hu S, et al. The role of M3 muscarinic receptor ligand-induced kinase signaling in colon cancer progression. Cancers. 2019;11(3):308.
  • Cauley K, Marks M, Gahring LC, et al. Nicotinic receptor subunits alpha 3, alpha 4, and beta 2 and high affinity nicotine binding sites are expressed by P19 embryonal cells. J Neurobiol. 1996;30(2):303–314.
  • Parnas D, Heldman E, Branski L, et al. Expression and localization of muscarinic receptors in P19-derived neurons. J Mol Neurosci. 1998;10(1):17–29.
  • Aydın B, M.Gören Z, Cabadak H. Investigation of the roles of non-neuronal acetylcholine in chronic myeloid Leukemic cells and their erythroid or megakaryocytic differentiated lines. Anticancer Agents Med Chem. 2019;18(10):1440–1447.
  • Teitz T, Wei T, Valentine MB, et al. Caspase 8 is deleted or silenced preferentially in childhood neuroblastomas with amplification of MYCN. Nat Med. 2000;6(5):529–535.
  • Shivapurkar N, Toyooka S, Eby MT, et al. Differential inactivation of caspase-8 in lung cancers. Cancer Biol Ther. 2002;1(1):65–69.
  • Liu Y, Zeng X, Hui Y, et al. Activation of alpha7 nicotinic acetylcholine receptors protects astrocytes against oxidative stress-induced apoptosis: implications for Parkinson’s disease. Neuropharmacology. 2015;91:87–96.
  • Parrish AB, Freel CD, Kornbluth S. Cellular mechanisms controlling caspase activation and function. Cold Spring Harb Perspect Biol. 2013;5(6):a008672–a008672.
  • Walsh CM. Grand challenges in cell death and survival: apoptosis vs. necroptosis. Front Cell Dev Biol. 2014;2:3.
  • Fujii T, Mashimo M, Moriwaki Y, et al. Expression and function of the cholinergic system in immune cells. Front Immunol. 2017;8:1085.
  • Kawashima K, Yoshikawa K, Fujii YX, et al. Expression and function of genes encoding cholinergic components in murine immune cells. Life Sci. 2007;80(24–25):2314–2319.
  • Salamone G, Lombardi G, Gori S, et al. Cholinergic modulation of dendritic cell function. J Neuroimmunol. 2011;236(1–2):47–56.
  • Koarai A, Ichinose M. Possible involvement of acetylcholine-mediated in flammation in airway diseases. Allergol Int. 2018;67(4):460–466.
  • Yang L, Cao Z, Yan H, et al. Coexistence of high levels of apoptotic signaling and inhibitor of apoptosis proteins in human tumor cells: implication for cancer specific therapy. Cancer Res. 2003;63(20):6815–6824.
  • Aydin B, Tulunay A, Ekşioğlu-Demiralp E, et al. Effects of carbachol on apoptosis in human chronic myelogenous leukemic K562 cell line. Marmara Med J. 2019;32:38–43.
  • Budd DC, McDonald J, Emsley N, et al. The Cterminal tail of the M3-muscarinic receptor possesses antiapoptotic properties. J Biol Chem. 2003;278(21):19565–19573.
  •  Sumet Amonyingcharoen; Tawit Suriyo; Apinya Thiantanawat; Piyajit Watcharasit; Jutamaad Satayavivad. 2015. p. 2317–2326.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.